Showing posts with label HIV. Show all posts
Showing posts with label HIV. Show all posts

Friday, September 9, 2016

PEP treatment if given within 8 hours, can help rape victims prevent HIV contraction

The initiative to administer this treatment should be taken by the relatives of the victim and also the law enforcement agencies which usually focus mainly on the crime angle, he suggested.

Rape victims can be prevented from contracting an HIV infection if a ‘post-exposure prophylaxis’ (PEP) treatment is given to them within eight hours of the sexual assault, a medical expert has claimed.

However, the treatment, which can prove to be life-saving for victims of sexual assault, is neither mandated nor is provided in India due to lack of awareness, AIDS Society of India (ASI) President Dr Ishwar Gilada told PTI.

“In cases of rape, along with legal aid a treatment of post-exposure prophylaxis should be immediately given to sexual assault victims. This will cut down the chances of infection to 100 per cent,” Gilada said.

A proactive three-day movement for creating public awareness for the use of PEP to prevent the spread of HIV infection in victims of sexual assault started in Mumbai from Saturday, where HIV clinicians from several medical faculties deliberated on how to put the evidences into a policy and take swift action.



“In a country like India, we have to work hard to put an end to sexual assault incidents. But warding off the fear of HIV infection is very easy, if all are made aware of the treatment,” he said.

The last few years have witnessed an alarming rise in rape cases in India. According to the National Crime Records Bureau (NCRB) statistics, 36,735 rape cases were reported in the country in 2014.

“In cases of rape, along with providing immediate trauma care, precaution should also be taken to ensure that the victim does not contract sexually transmitted diseases (STD), including HIV,” he said.

“In order to alleviate the danger of HIV infection, PEP should be administered to the victims. This is a short term, inexpensive and an anti-retroviral treatment (ART) which can prove effective if started within eight hours of the rape incident,” Gilada said.
The initiative to administer this treatment should be taken by the relatives of the victim and also the law enforcement agencies which usually focus mainly on the crime angle, he suggested.

ASI is a professional non-profit organisation of medical doctors and researchers in HIV/AIDS aiming to promote and disseminate clinically-oriented medical teaching and coordinated medical management of HIV disease.

National AIDS Research Institute’s (NARI) Director In-charge and ASI’s annual national conference ASICON 2015 Co-Chairman, Dr Raman Gangakhedkar said the latest WHO guidelines on HIV make available two key recommendations that were developed during the revision process this year, one of them being administration of PEP.
“Daily use of oral post-exposure prophylaxis is recommended as a prevention choice for people at substantial risk of HIV infection as part of combination prevention approaches,” Gangakhedkar said.

“In any case of sexual assault or an accidental exposure to HIV infection, like condom rupture between two partners, this treatment would help reduce the risk by 100 per cent. More and more awareness would help to control this infection in India,” he said.
In 2013, the World Health Organisation (WHO) had issued consolidated guidelines on the ‘Use of anti-retroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach’.

Thursday, March 3, 2016

HIV hides and grows inside the body even when undetectable in blood

HIV can hide and grow in body ‘sanctuaries’ after disappearing from blood, study says

Researchers pinpoint how HIV hides and grows inside the body even when undetectable in blood


HIV continues to replicate in the body even if it’s undetectable in the blood after antiretroviral treatment, scientists have discovered.

It explains how the virus rapidly bounces back – and keeps growing – after a patient stops taking antiretroviral drugs.
Study author Dr Steven Wolinsky, chief of infectious diseases at Northwestern’s Feinberg School of Medicine, said: ‘We now have a path to a cure.

‘The challenge is to deliver drugs at clinically effective concentrations to where the virus continues to replicate within the patient.’


Potent antiretroviral drugs are able to seemingly get rid of HIV from the bloodstream in most patients.
After the treatment, their blood tests may not detect the virus.
However, HIV is still growing in a viral reservoir within the lymphoid tissue in the body at that time.
And, it ‘quickly rebounds’ in the blood after patients stop taking the drugs.

Scientists concluded that latently infected cells or ongoing low levels of HIV replication maintain those viral reservoirs during antiretroviral treatment.
Scientists long believed that the reservoir only contained long-infected cells in a resting place – instead of newly infected cells.


That’s because none of them had seen viruses with new genetic mutations that arise when HIV completes its growth cycles.
Furthermore, most patients don’t develop drug resistant mutations – which would seem likely if HIV was growing in the presence of drugs.
The study analyzed viral sequences in serial samples of lymph node cells.
They also examined blood from three HIV-infected patients.
Each of those patients had no detectable virus in their blood.
The scientists determined that the viral reservoir was constantly replenished by low-level virus replication in the lymphoid tissue.
Infected cells would then move from those ‘protected sanctuaries’ and into the blood, they found.
Therefore, infected cells in drug-sanctuaries within the lymphoid tissue can still produce new viruses.


HOW HIV INFECTS

HIV infects CD4+ T-cells, which play a vital role in the immune system and protect us from diseases. As HIV progresses, it reduces the number of active T-cells in the body until the immune system cannot function correctly, a state known as 'acquired immune deficiency syndrome' or AIDS.
Current World Health Organisation guidelines, which the UK government follows, recommend only beginning HIV treatment when the number of T-cells in the bloodstream falls below a certain level.
However, the new model predicts that treatment should start as soon as possible after infection to prevent AIDS from developing in the long term.

They can also infect new target cells and replenish the viral reservoir.
That’s why drugs have not been able to completely purge the body of latently infected cells – and kill the virus all together.

The scientists utilized a mathematical model to track the amount of the virus and number of infected cells as they grew in the sanctuaries – and as they then moved through the body.
The model showed that HIV grows in areas where antiretroviral drug concentrations are lower than in the blood.
The scientists concluded that it is important to deliver high concentrations of antiretroviral drugs to all locations in the body where HIV may grow and evolve.
As such, drugs that penetrate these ‘newly discovered sanctuaries’ will be required to eliminate the viral reservoir – and may bring the medical community closer to finding a cure.
Co-author Dr Angela McLean, a professor of mathematical biology at Oxford University, said: ‘The study is exciting because it really changes how we think about what is happening in treated patients.
‘It helps explains why some strategies that tried to clear the reservoir have failed.’
The study was published in the journal Nature. 


A new study shows that HIV can still live and grow in the body even after disappearing from the blood following aggressive antiretroviral therapy.

The research, published in the journal Nature on Wednesday, involved looking at samples of cells from the lymph nodes of three patients who appeared to have cleared the virus. The researchers found that cells in the lymph node tissue can still produce new viruses and infect new target cells.

The groundbreaking idea of viral reservoirs of HIV made headlines in July 2014 when a Mississippi girl born with HIV, who was believed to be cured after early treatment, tested positive for the virus after stopping therapy. In her case, doctors think the infection reemerged from a viral reservoir that contained cells in a resting state that were not proliferating.

The latest study, funded by the US National Institutes of Health, appears to show a different type of “sanctuary,” as the researchers called it, that harbours cells with low levels of HIV replication that move into the blood. Researchers used a mathematical model to track the amount of virus and the amount of infected cells as they grew and moved through the body.

This suggests that virus growth could occur in a place where drug concentrations are very low.

“These findings are important as it is critical for the field of HIV cure research to know whether new infectious cycles are indeed continuing in patients on seemingly effective treatment,” said Deborah Persaud, a professor of infectious diseases at Johns Hopkins University School of Medicine.

But Persaud, who was not involved in the lymph node research but was part of a team caring for a baby who had received a treatment similar to the Mississippi child, said the study is limited by its small sample size and the fact that the analyses were done during the first six months of combination treatment “when the infected pools are still very dynamic.” She said a similar study on patients with longer-term treatment may offer more clues about what is going on.

Co-author Steven Wolinsky, chief of infectious diseases at Northwestern University Feinberg School of Medicine and a Northwestern Medicine physician, said in a statement that the research indicates that “the challenge is to deliver drugs at clinically effective concentrations to where the virus continues to replicate within the patient.”

Angela McLean, a professor of mathematical biology at Oxford University and who supervised the mathematical modeling, added that the study “really changes how we think about what is happening in treated patients.”

“It helps explain why some strategies that tried to clear the reservoir have failed,” she said.

Tuesday, January 12, 2016

India Adds More HIV/AIDS, Cancer Drugs To Essential Medicines List

The government has revised its list of essential medicines to add drugs for diseases ranging from cancer and HIV/AIDS to hepatitis C, in a move aimed at making them more affordable.

The update to the National List of Essential Medicines (NLEM) is just the third since it was compiled in 1996.

It increased the list to 376 medicines from 348 and includes drugs ranging from analgesics and antivirals to contraceptives, cardiovascular and anti-tuberculosis drugs.

Reuters reported in April that more HIV/AIDS and tuberculosis medicines were likely to be added to list, which is posted on the Central Drug Standard Control Organisation's (CDSCO) website.

"The NLEM 2015 has been prepared adhering to the basic principles of efficacy, safety, cost-effectiveness; consideration of diseases as public health problems in India," a notice on the website said.

India had been criticised because the former list left out some life-saving drugs.

The new list takes cues from the World Health Organisation's 2015 list of essential drugs, which the United Nations agency defines as those that satisfy the priority healthcare needs of people and ensure affordability.

The revision comes after months of deliberations by a committee of experts formed by the government last May. Views of the pharmaceutical industry and NGOs were also considered, the CDSCO said.

The committee recommended that the list, which is effective immediately, be revised every three years.

In initial thoughts, industry executives said they were yet to study the list's impact.

"We will be seeking clarification and a better understanding of its implications," said Ranjana Smetacek, director general of the Organisation of Pharmaceutical Producers of India (OPPI) which represents large foreign drugmakers.

The Indian Pharmaceuticals Alliance, which represents large local drugmakers, did not respond to requests for immediate comment.

It is likely that medicines in the new list will be brought under price control, as was done with the previous list, some in the industry said.

Drug pricing is a contentious issue in the country, as nearly 70 percent of the population lives on less than $2 a day and health insurance is inadequate.

India contributes roughly 1 percent of its total gross domestic product to healthcare, among the lowest levels of funding in the world.

Industry executives say drug prices in the country are also among the lowest in the world.

India's drug pricing regulator has struggled in the past year to implement price caps and expand them to cover more drugs.

When it fixed prices of about 100 medicines citing public interest last year, the industry fired back with lawsuits.

The government soon curbed the National Pharmaceutical Pricing Authority's (NPPA) powers, restricting it from fixing the price of medicines not on the essential medicines list.

Price caps cover roughly 30 percent of the drugs sold in the country.

India reports 32 percent declining in HIV/AIDS

India is estimated to have registered a 66 per cent decline in new HIV infections from 2000 and 32 per cent decline from 2007, according to the latest round of HIV sentinel surveillance and estimations conducted by the National AIDS Control Organisation (NACO), released by the Union Health Ministry.

There were around 86,000 new HIV infections in 2015. The report noted that Andhra Pradesh and Telangana, Bihar, Gujarat and Uttar Pradesh currently account for 47 per cent of the number of total new infections among adults with each of these States contributing 7,500 or more new infections in 2015.


West Bengal and Rajasthan registered more than 5,000 new HIV infections, but less than 7,500 new infections, while Maharastra, Odisha and Tamil Nadu have new infections in the range of 3,000-4,000. Chhattisgarh, Delhi, Haryana, Jharkhand, Karnataka, Madhya Pradesh and Punjab have 1,000-2,400 new infections among adults and the rest of the States have less than 1,000 new adult HIV infections in 2015.


New infections among adults have declined by 50 percent or more in the State of Andhra Pradesh and Telangana, Karnataka, Maharashtra, Manipur and Odisha during 2007-2015. Bihar, Jharkhand, Kerala, Mizoram, Nagaland, Rajasthan and Uttarakhand are the states where annual new infections declined by 32-47 percent during the same period.

However a rising trend in new infections among adults during 2007-2015 has been detected in Assam, Chandigarh, Chhattisgarh, Gujarat, Sikkim, Tripura and Uttar Pradesh.

The report further noted that since 2007, the number of AIDS-related deaths declined by 54 percent in 2015 with an estimated 67,600 people dying of AIDS-related causes nationally.

The annual number of AIDS deaths has declined by 70-81 per cent during 2007-2015 in Karnataka, Maharashtra and Tamil Nadu. Annual AIDS related deaths declined by 60-70 percent from baseline values of 2007 in Andhra Pradesh and Telangana, Goa, Himachal Pradesh and Nagaland, while a decline of 40-47 percent was estimated in Chhattisgarh, Gujarat and Punjab.

Injectable HIV Treatment Would Change Lives

This month ViiV Healthcare and Janssen Sciences announced that Phase III trials for a bimonthly HIV treatment injection would begin in mid-2016. This year the two 

companies will be evaluating the commercialization of a long-acting formulation to be used as an injectable maintenance treatment for patients who have achieved viral suppression. 

Injectable treatments have been the buzz in HIV treatment research for a while, but this announcement represents a tangible hope that a new form of treatment is within our grasp. In a few years, many people living with HIV might be able to throw away their pillboxes for good.

The current oral regimen continues to be a reason for poor adherence to HIV treatment. Also, the daily pill can sometimes be viewed as a symbol of second-class status. 

No matter how healthy I am, people still see someone whose health is subpar.

In the U.S., the majority of people living with HIV are not able to stay on treatment and maintain viral suppression. The possibility of a bimonthly injection wouldn’t just improve adherence to medication and reduce transmission, it would revolutionize the lives of HIV-positive people.

If you are not living with HIV, just try to imagine it for a second. Imagine being a young person and being told that you can still live a long and healthy life, but only if you adhere to this daily regimen with few to no mistakes. Sounds simple enough, but factor in trying to carry the enormous weight of HIV stigma and concealing 

your diagnosis to the outside world — as most initially try to do — and you have 365 reasons to fail. For so many, a bottle of pills isn’t just a bottle of pills, but an embarrassing reminder to yourself and others, that you contracted a virus that is avoidable.

That sounds harsh. HIV shouldn’t have to be something people are ashamed of. But what should be does not change the reality of the majority of people with HIV who are utterly mortified and almost paralyzed by the idea of people finding out their status.

Now, imagine being told that all it will take to keep you healthy and living the life you want is six doctor visits a year. Sure, it may not still ideal, but what disease is? It is a hell of a lot better than the alternative. An HIV injectable treatment represents an opportunity to resume life knowing that you are virally 

suppressed even if you are not quite ready or able to take on managing your virus full time.

Today, managing HIV doesn’t just require a daily pill. It requires a person to develop an entirely new state of mind — one that requires strength, an awareness of what it means to be positive today, and the support of friends and loved ones. If that were so easy to come by, HIV wouldn’t still be the problem that it is.

An injectable treatment would remove the daily reminder of a disease that shouldn’t but often does hold people back. It would mean the freedom of waking up and going about your day without a siege of panic because you forgot to take your medication. It would mean the removal of shackles to a pill bottle so sleepovers can be spontaneous and packing for vacations is done sans stress. Frankly, an injectable treatment would simply mean a better life.

Indiana town adopts B.C.’s HIV-treatment model after outbreak

A small Indiana community where two out of every five residents are considered at high risk of HIV infection is reaching out to B.C. experts for help.

Austin, Ind., is suffering through an unprecedented outbreak of the disease. With a population of 4,200, 10 per cent are currently injecting prescription opioid drugs on a daily basis, said Diane Janowicz, assistant professor at the Indiana University School of Medicine.

Since last year, 184 new HIV infections have been identified.

“Thirty-nine per cent of the population are identified as high risk. That’s an incredibly high prevalence compared to other parts in the U.S.,” Dr. Janowicz said.

The university, working with the National Institute on Drug Abuse, has asked for help from the BC Centre for Excellence in HIV/AIDS. The intention is for the centre to bring its so-called treatment-as-prevention model of health care to the beleaguered community. Treatment-as-prevention is a collection of antiretroviral treatments that reduce the HIV virus load in blood and vaginal and rectal fluids, to decrease the risk of HIV transmission.

B.C. has seen a steady decrease in the number of deaths resulting from HIV since the introduction of an intense antiretroviral therapy program that began in 1996. There has been a 90-per-cent decrease in the number of new cases since 30 years ago.

As of last year, only 250 cases of HIV were recorded in B.C.

In Austin, the outbreak began last year and is linked to intravenous injection of opiate pain medication that users crush. It has prompted a warning from the U.S. Centers for Disease Control and Prevention to alert health officials to be on guard against clusters of HIV and hepatitis C infections.


“Indiana University will bring their colleagues here to see how we implemented our strategies in British Columbia, to learn about our treatment programs and to see how we have made the improvement happen,” said Julio Montaner, director of the BC Centre for Excellence of AIDS/HIV.

“It’s easier said than done. This program is very complex and it is difficult to implement,” he said.

For example, he said it can be difficult for doctors to reach patients and ensure they have access to the kinds of drugs and programs needed for the therapy to be effective.

A state epidemiologist said in a news report in the Indy Star last year that fewer than half those diagnosed with HIV had been prescribed antiretroviral treatments.

Prior to the outbreak in Austin, there was only one clinic providing health care in the town.

The Indiana team, including the B.C. doctors, plans to use mapping technology to examine risk factors for HIV transmission. Other research will investigate the clustering of HIV transmissions. And scientists will evaluate how to counter the damage of injection-drug use through harm-reduction services.

“The situation in Indiana marks a critical need for implementing best practices in harm reduction and HIV prevention. Treatment-as-prevention is a model for opening up access to early HIV treatment and care, for reducing stigma and for targeted disease elimination,” Dr. Montaner said in a news release.

“Providing sustained, consistent treatment and care ensures that an individual’s viral load decreases, dramatically reducing the likelihood of disease progression and secondarily stopping HIV transmission.”

B.C.’s treatment model has also been widely adopted in other jurisdictions of the world including China, Latin America and Europe.

“The BC Centre for Excellence in HIV/AIDS is recognized internationally for [its] outstanding work in providing access to treatment and care for those affected by or at high risk of HIV in urban and rural areas in British Columbia,” Dr. Janowicz said.

Sunday, December 27, 2015

H.I.V. Education That Aims to Empower

Thanks to medical advances, a diagnosis of H.I.V., while still very serious, is no longer the death sentence it once was. For organizations trying to communicate information about testing and prevention, though, the devastation the virus has caused over the decades remains ever-present.

Traditional public service announcements tend to rely on shock and shame, with mixed success. But when Arizona public health officials began contemplating a new campaign, they wanted to change that.

“We needed a coordinated media strategy and it needed really to focus less on fear-based messaging and more on empowering people,” said John Sapero, office chief for H.I.V. prevention for the Arizona Department of Health Services.

About a year ago, the health department turned to one of its regular media partners, the marketing agency Moses Inc., to create a P.S.A. aimed at encouraging people to visit a website, HIVAZ.org, where they could get information about testing and other resources.

The ads, displayed on billboards, bus shelters and other outdoor areas in the Phoenix and Tucson areas, each depict a person going about an everyday activity — jogging, shopping, talking on the phone — and encountering an unnoticed hazard: a street signpost, a glass door, an open manhole cover.

“It’s only dangerous if you don’t know it’s there,” the ads say. The HIVAZ.org web address and the phrase “Awareness is the answer” are at the bottom. The campaign also has a digital component intended to direct people to the site.

“Slipping or bumping into a door — all of us do it, and it’s dangerous if you don’t know it’s there,” said Louie Moses, president and creative director of Moses Inc. The ultimate goal is to get people to visit the website, he said, where they can receive information about getting an H.I.V. test. The site also offers support resources for patients and information about how people can reduce their risk of contracting the virus.

The initiative had its challenges. The ads had to address a serious topic on a shoestring budget, not to mention the agency had to figure out how to make a pair of headphones look as if they were flying off a jogger’s ears.

To create the eye-catching images, Moses Inc. tapped the advertising photographer Blair Bunting, known for his work capturing athletes in motion, to stage the moments of “impact.”

“The images best represented what we felt like H.I.V. could be for someone who contracted it,” Mr. Bunting said.


He added, “You have to have this image that makes it look like control has been lost.”

The entire campaign had a budget of $300,000, money that the Centers for Disease Control and Prevention distributed to the Arizona Department of Health Services.

With those constraints, Mr. Bunting and his crew had to make the most of their studio time to create the trio of images, using equipment like wind machines and a riser to create the appearance of a person plunging headlong into an unpleasant situation.

Mr. Moses said if the project had been a conventional ad campaign, underwritten by a corporate advertising budget, the cost would have been $5 million to $10 million.

The agency donated “literally hundreds of hours,” he said, while Mr. Bunting said he worked with about 20 percent of his usual budget for the shoot. In addition, Aunt Rita’s Foundation, a nonprofit that works with Arizona’s health department on H.I.V. awareness and prevention, was able through its partners to secure donations of space to display some of the ads.

The efforts have paid off, Mr. Sapero said. Last fall, the HIVAZ.org site had about 9,000 new visitors over a period of about two months. This year, after the campaign began, that figure jumped to 39,000 over the same time period, while the number of repeat visitors to the site rose from 15 percent of overall visitors to more than 40 percent.

“Clearly, people are coming to the site, seeing what it’s about,” he said. “They’re bookmarking it and they’re coming back again.”

The campaign clicked with viewers because it eschewed shaming and judgment, said Nidhi Agrawal, professor of marketing at the University of Washington, who has studied the effect of P.S.A.s for drinking and driving. “You’re taking the stigma away, and when we create distance from the stigma, people can think about it more objectively.”

Mr. Moses said advertisers and nonprofits have learned a great deal about how to communicate messages about H.I.V. since the disease first came onto the national radar in the 1980s.

“We did some pretty shocking ads back then,” he said. “At the time we didn’t know any better, and we wanted to get awareness; we wanted people to know the name AIDS.” Current campaigns tend to focus on H.I.V., the virus that causes AIDS, because health officials and advocates want to connect with patients before the disease progresses to AIDS.

“We kind of learned from the past we didn’t want to shock and scare and judge the group of people we were talking to,” Mr. Moses said. “Since then, the research says that shocking and embarrassing and shaking your finger at the potential consumer does the exact opposite. It just makes them hide.”

Ms. Agrawal agreed that eliciting negative emotions backfires, because people then focus on their feelings instead of absorbing the message. “People are too busy managing the shame and the fear to respond to the P.S.A. or respond to the problem,” she said. (A recently unveiled campaign in cities like New York and San Francisco that is focused on H.I.V. prevention strikes a similar tone to Arizona’s.)

Mr. Bunting said they wanted the Arizona P.S.A. to circumvent those feelings.

“It wasn’t very heavy-handed,” he said. “It made it comfortable for people to talk about something that’s usually a very uncomfortable situation.”

HIV rates still high despite innovations in treatment

Scientific advances for HIV/AIDS have exploded in recent years, and doctors have new ways both to treat people who already have the disease and to prevent others from acquiring it.

But despite new research that allows scientists to track, treat and prevent HIV better than ever before, the disease continues to spread, including in Louisiana.

Baton Rouge is ranked first in the nation for estimated HIV and AIDS case rates per 100,000 people, while New Orleans is ranked third for HIV and fourth for AIDS, according to newly released 2014 Centers for Disease Control and Prevention figures.

How to link people infected with the disease to health care and why they continue to go untreated are questions that physicians nationwide — and in Louisiana — are trying to answer.

A recent New England Journal of Medicine article titled “Applying Public Health Principles to the HIV Epidemic — How Are We Doing?” offered a somewhat pessimistic view of the status quo. In the essay, Dr. Thomas Frieden, the director of the Centers for Disease Control and Prevention, and his co-authors called for doctors, as well as local and state health agencies, to adopt a more aggressive approach to combating the spread of the disease, pointing to alarming trends.

Advocate staff photo by TRAVIS SPRADLING -- East Baton Rouge Parish Coroner Dr. Beau Clark speaks during his  annual report Tuesday at Cafe Americain, detailing the past year, changes he's made and what's  ahead for 2015. Coroner: Heroin overdose deaths at record high in East Baton Rouge Parish; most victims white males
Baton Rouge police: Biter exposes victim to HIV, says victim owes him money
Man accused of intentionally exposing partner to HIV virus
Bill to allow HIV tests for inmates clears Louisiana Senate
“Most people living with HIV infection in the United States are not receiving antiretroviral treatment; notification of partners of infected people remains the exception rather than the norm; and several high-risk behaviors have become more common,” they wrote.

DeAnn Gruber, the HIV program director for Louisiana’s Department of Health and Hospitals, said she read the article as highlighting that the nation is at a crossroads in terms of HIV care.

“We’re at a real turning point in the epidemic of HIV,” Gruber said. “What they’re raising too is that even though there have been some advances, there’s still a lot of work to be done.”

At-risk communities
The work is particularly needed within smaller, often stigmatized communities.

In line with national trends, gay men contract half of all of the new HIV infections in Baton Rouge, said Timothy Young, the head of the HIV/AIDS Alliance in the Baton Rouge area.

Last year, around 24 percent of the more than 5,000 people living with HIV/AIDS in Baton Rouge were not receiving care related to the disease, according to DHH and CDC estimates.

As for preventing the spread of HIV, Young said that just telling people to have safe sex is not enough.

“There is a disconnect between that knowledge and behavior. We know that trying to teach increased and effective condom use has not been effective,” Young said.

Gruber said smaller subsets of gay and bisexual men, particularly black gay men, have higher risks of being exposed to the disease. Young said the reason involves more than race and sexual orientation, and even geography can come into play.

“People tend to have sex within their own race and ethnic groups within a relatively small geographic area,” Young said.

HIV tends to spread in some communities because of risky behaviors, such as anal sex without condoms. But other risky behaviors are on the rise as well.
Increases in opiate use nationwide have led to more HIV infections from needle-sharing, according to the CDC essay.

Baton Rouge has certainly felt the strain of opiate-usage increases, as the city recorded a record number of heroin deaths this year.

Health experts know that needle sharing and unprotected sex are problems, and they know which communities they most affect. But transforming that knowledge into action is difficult, they say.

Young, DHH and many public health experts are strong advocates of “pre-exposure prophylaxis,” a daily pill called Truvada that people with risky lifestyles can take to prevent getting HIV.
A CDC report from November said the daily pill could reduce the risk of HIV acquired from sex by 90 percent and of HIV from drug injections by 70 percent. But the CDC also estimated that one in three primary care doctors and nurses do not know about the treatment, meaning it is not as widespread as it could be.
Possible solutions
Young said the key to combating HIV is identifying every member of the community who is infected with the disease, linking them to treatment and spreading messages about prevention.

The CDC essay heralded an effort in San Francisco, where a combination of increased testing, partner notification and treatment led to a 40 percent decrease in new HIV infections between 2006 and 2014.

Gruber said New Orleans recently received two grants, totaling $5 million over the next few years, that could help build a San Francisco-like model in that city. She said the money will be directed toward building networks that address behavioral health, housing, employment and transportation for people with HIV.

Gruber said it’s likely that DHH will pluck the most successful aspects of what they do in New Orleans and implement them in Baton Rouge.

One of the state’s most successful initiatives, called “LA Links,” focuses on identifying people who are HIV-positive and connecting them to medical care and support services. The program exists in Baton Rouge, New Orleans and Shreveport, and is set to expand.
Within its two-year existence, Gruber said, around 500 people have enrolled in “LA Links.” About 87 percent of them have started receiving medical treatment.
The New England Journal of Medicine article also emphasizes the importance of newly diagnosed people reporting their partners so that they can get tested. The doctors who authored the study argue that reporting partners is a critical way to trace and stop the spread of the disease.

“Despite the importance of these services, interviews to elicit names and contact information of partners were documented to have been conducted with only about half the people who received a diagnosis of HIV infection in 2014, and patients who named partners named relatively few,” they wrote.

Louisiana state law does not require people to report their sexual partners, but Gruber said the state’s partner services office works hard to have people disclose their partners and then to inform those people of their potential exposure to HIV.

Young said asking people to name partners does not always yield results, for some people will not be honest, some do not remember and others simply do not know. He said the rise of hookup apps, like Grindr — a social networking app that lets users share their location — has led to many fleeting relationships that could make it more difficult for people to report their sexual partners.

“That’s not necessarily a positive sign when we’re trying to control the high rate of STDS that we have here in Louisiana,” Young said.

Barriers to treatment
Stigma is still the biggest barrier to getting people into testing and treatment, Young said.

He said the fear of being associated with HIV is so pronounced that more than 25 percent of those who are newly diagnosed with the disease in Louisiana have already progressed to AIDS.

“We have people who don’t want to test, don’t want to be seen accessing care or going to known providers of HIV care, and are living with the situations that may have allowed them to become HIV-positive in the first place,” Young said.

The good news for people who worry about the stigma of having HIV is that treatment is better than ever, Young and Gruber said.

HIV is no longer a death sentence with a ticking clock; people with the disease who are in treatment can live normal life spans and healthy lives.

It’s unclear how much of a game changer Medicaid expansion might be for treating people with HIV/AIDS in Louisiana. While Gov. Bobby Jindal has declined to expand Medicaid, the federal health insurance program for the poor, Gov.-elect John Bel Edwards has said he wants that to be among his first moves once he takes office.

J.T. Lane, DHH’s assistant secretary for public health, said the state already covers HIV testing and that clinics that are federally qualified health centers can reimburse patients.

DHH spokeswoman Ashley Lewis said that if Medicaid is expanded, it would open up more avenues for recipients to receive overall medical coverage and it could increase specific types of federal funding for people in the state with HIV/AIDS.

Young said the state needs to do more, although he acknowledged that HIV treatments are largely covered for patients right now because of specific federal funding in that area.

“We also know that Louisiana doesn’t have any skin in the game in the sense that there are currently no state dollars dedicated to HIV prevention, which is very sad when we have some of the highest rates,” Young said.

Tuesday, December 15, 2015

United States HIV cases down 20 percent


U.S. HIV cases down 20%, but up 87% for 2 groups


Southern states currently have greatest incidence of HIV infection, CDC says

While the overall number of HIV diagnoses continues to fall in the United States since the first cases were documented 30 years ago, at least two groups of the population are seeing a sharp increase in those numbers.

A report by the Centers for Disease Control and Prevention released this month shows a nearly 87% increase in the number of HIV diagnoses of African-American gay and bisexual males and Latino gay and bisexual males, aged 13-24.

Overall, the number of diagnoses for the entire population dropped by 19% from 2005-2014, the analysis showed.

A risky environment

There is a high prevalence of HIV in the African-American gay and bisexual community, according to Dr. Eugene McCray, director of the CDC's Division of HIV/AIDS Prevention.

"If you are a young black man, and are having sex with other black men, your chance of being exposed is really high," he said.

Part of the problem, he said, is the low rate of condom use in that community.

Adding to the risk is the fact that nearly a third of black gay and bisexual men between the ages of 13-24 who are HIV-positive don't know it, said Dr. Jonathan Mermin, director of the CDC's National Center for HIV/AIDS, Viral Hepatitis, STD, and Tuberculosis Prevention.

"A fair proportion haven't been diagnosed. It creates a risky environment," Mermin said.

In all ages of black gay and bisexual men, the number of diagnoses increased 22% over the past decade, but those rates have been leveling off since 2010, the CDC report showed. Latino gay and bisexual men of all ages have also seen their number of HIV diagnoses rise by 24% over the past 10 years.

In the same time period, the number of HIV cases has dropped 35% among heterosexual adults, 63% among intravenous drug users, and 22% among all African-Americans, according to the CDC. Women have also seen a significant decline in HIV infections, down 40%, from 12,499 diagnoses in 2005 to just 7,533 in 2014, with the biggest drop occurring among African-American women, who have seen the number of cases nearly drop in a half, from 8,020 HIV diagnoses in 2005 to 4,623 in 2014.

Southern states have highest incidences of HIV

Across the country, Southern states currently have the greatest incidence of HIV infection, illness and death. In fact, while the South represents about a third of the general population, it is home to 44% of those who are HIV-positive. Those individuals are also three times more likely to die than those with HIV living in other parts of the country.

Mermin said it's very important to target groups that have been disproportionately impacted by HIV with more intervention.

"We have to accelerate access to HIV testing, treatment and prevention, including PrEP (Pre-Exposure Prophylaxis), to those at greatest risk," he explained.

Today, more than 1.2 million people in the United States are HIV-positive. About one in eight of those infected are unaware of their status.

Zimbabwe children still at great risk of HIV/AIDS new data shows

Janet Dube knows the pain of raising a child born with HIV.


Her four-year-old son is one of an estimated 170,000 children living with HIV/AIDS in Zimbabwe, and figures released by the country's statistics agency on Wednesday showed the virus is the leading cause of death among children under five.


A Census Analysis Mortality Report from 1992-2012 revealed that despite progress in fighting the virus, HIV and AIDS had claimed the lives of thousands of Zimbabwean children under five.

"I live in constant fear about my child's health as he sometimes skips medication when we fail to travel to the city (Bulawayo) to get (medication)," Dube, 27, from Filabusi, about 100km (60 miles) from Bulawayo, told the Thomson Reuters Foundation.

Dube, however, is one of the lucky HIV patients who gets free antiretroviral therapy (ART) from a government hospital, though she sometimes goes without medication for herself and her son when she does not have the bus fare to travel to Bulawayo.

When her son goes without medication, it increases her concern about whether he will live long enough to go to school.

About 17 percent of Zimbabwean adults, more than 1.4 million, live with HIV and AIDS, according to UNAIDS figures, making the southern African nation one of five African countries where around 20 percent of adults have HIV or AIDS.

According to the Zimbabwe Network of People Living with HIV's (ZNNP+) executive director, Muchanyara Mukamuri, only 40 percent of children in Zimbabwe who need it are receiving antiretroviral therapy.

Dube said a lack of adequate nutrition adds to her concern about her and her son's health as Zimbabwe's rural areas are facing acute food shortages.

"We just don't have enough to eat," said Dube, a single mother who receives monthly food assistance from a Bulawayo church.

The United Nations Population Fund (UNFPA) Zimbabwe residentrepresentative, Cheikh Tidiane Cisse, said that while the number of children dying before the age of five had fallen in the past three decades, more still needed to be done in the HIV/AIDS sector.

"Access to antiretroviral therapy and antenatal care must be increased," Cisse said.

Zimbabwe's long-running economic crisis has not spared the health sector, and there have been large cuts in public health spending.

Last month, Finance Minister Patrick Chinamasa allocated $301 million to the health and child welfare ministry, but public health campaigners and experts said domestic funding for HIV and AIDS remained inadequate.

In September, the United States approved funding of $95 million under the President's Emergency Plan for Aids Relief (PEPFAR), which is also expected to increase the supply of antiretroviral therapy for children.

As for Dube, she can only hope.

"Each day I blame myself (for her son's condition), I wish one day they get a cure (for HIV)," she said.

Man with HIV charged with exposing woman to disease knowingly

A man accused of knowingly exposin a woman with HIV in 2014 is facing charges in Sumter.

Dexter Durham, 41, was arrested November 12 in North Carolina after authorities say he has been on the lam since August of 2014.

A woman contacted police in 2014 saying that Durham knowingly exposed her to HIV between 2010 and 2012.

He has since been charged with failure to report a contagious/infectious disease. Investigators said Durham learned of his infection in 2005 and may have exposed others to the disease.

The 41-year-old has since been released on bail. If convicted he faces a fine up to $5,000 and a maximum of 10 years in prison.

Authorities are asking if you have any more information on this case to call Sumter Police at 803-436-2700 or CrimeStoppers at 1-888-CRIME-SC.